AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...
Few companies have been able to fundamentally change their operating and business models around AI. The primary obstacle to ...
These new models are specially trained to recognize when an LLM is potentially going off the rails. If they don’t like how an interaction is going, they have the power to stop it. Of course, every ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results